Unity Biotechnology, Inc. (0YC0.L)

USD 1.02

(-1.45%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - 236 Thousand 4.78 Million - - -
Cost of Revenue 19.69 Million 2.18 Million 2.88 Million 3.44 Million 2.66 Million 2.18 Million
Gross Profit -19.69 Million -1.94 Million 1.9 Million -3.44 Million -2.66 Million -2.18 Million
Operating Expenses 44.66 Million 57.8 Million 61.44 Million 91.33 Million 91 Million 74.92 Million
Selling, General and Administrative Expenses 18.76 Million 20.94 Million 23.05 Million 24.02 Million 20.04 Million 16.01 Million
Research and Development Expenses 20.09 Million 36.85 Million 38.39 Million 67.3 Million 70.95 Million 58.9 Million
Other Expenses - -17 Thousand -983 Thousand 182 Thousand 4.18 Million -245 Thousand
Cost and Expenses 44.66 Million 57.8 Million 61.44 Million 91.33 Million 91 Million 74.92 Million
Operating Income -44.66 Million -57.57 Million -56.66 Million -93.93 Million -89.65 Million -79.46 Million
Interest Expense - 3.55 Million 3.17 Million 1.29 Million - 3.31 Million
Income Tax Expense - -2.18 Million -686 Thousand -1.97 Million -7.3 Million 3.06 Million
Earnings before Tax -39.86 Million -59.92 Million -60.72 Million -93.84 Million -82.17 Million -76.39 Million
Net Income -39.86 Million -57.74 Million -60.03 Million -91.86 Million -74.87 Million -76.39 Million
Earnings Per Share Basic -2.70 -6.08 -10.76 -18.06 -17.16 -27.02
Earnings Per Share Diluted -2.70 -6.08 -10.76 -18.06 -17.16 -27.02
Weighted Average Shares Outstanding 14.77 Million 9.49 Million 5.58 Million 5.08 Million 4.36 Million 2.82 Million
Weighted Average Shares Outstanding (Diluted) 14.77 Million 9.49 Million 5.58 Million 5.08 Million 4.36 Million 2.82 Million
Gross Margin - -8.24 0.40 - - -
EBIT Margin - -238.85 -12.03 - - -
Profit Margin - -244.69 -12.55 - - -
EBITDA -37.28 Million -38.73 Million -54.66 Million -89.1 Million -89.65 Million -74.21 Million
Earnings Before Tax Margin - -243.95 -11.84 - - -

Income Statement Charts